The Beauty Health (SKIN) - Multiplikator Forward P/S

Logo korporat perusahaan The Beauty Health (SKIN)

The Beauty Health is developing the HydraFacial platform, relying on a consumables sales model to ensure a stable cash flow. The forward price-to-sales ratio demonstrates the business valuation dynamics, where the 0.40 level indicates the parameter's status. The growth of the clinic network and expansion into new regions support the capitalization, despite temporary saturation in the retail segment of the aesthetics market.

BeautyHealth - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep SKIN (periode 04.07.2022 - 16.11.2026)

Rincian metrik lan analitis perusahaan Beauty Health (SKIN)

- rega saham lan target rega konsensus:
Analisis umum perusahaan:Beauty Health (SKIN)
Produk sing diprodhuksi The Beauty Health Company

Investors must weigh market expectations against the actual resilience of The Beauty Health (SKIN) amid falling demand for high-end aesthetic care driven by global instability. The forward P/S ratio is calculated as the ratio of market capitalization to expected revenue, allowing analysts to identify asset overbought conditions through chart analysis and timely hedge risks stemming from rising equipment maintenance costs and logistical disruptions.

Analisis pesaing

Multiplikator Forward P/S HCA (HCA Healthcare, Inc.)|Rasio rega marang pendapatan sing dikarepake THC (Tenet Healthcare)|FMS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep solventum.com|EHC: Multiplikator Forward P/S|UHS - Rasio kapitalisasi marang dodolan sing dikarepake|DVA (DaVita Corp) - Multiplikator Forward P/S|RDNT: Rega forward marang dodolan|Multiplikator Forward P/S OPCH|SGRY (surgerypartners.com) - Rega forward marang dodolan|Multiplikator Forward P/S PINC (Premier Inc)|National Vision - Rasio rega marang prakiraan pendapatan|PGNY - Rasio rega marang prakiraan pendapatan|ARDT - Multiplikator Forward P/S|SEM: Multiplikator Forward P/S|astranahealth.com (ASTH) - Multiplikator Forward P/S|MD (mednax.com) - Multiplikator Forward P/S|Multiplikator Forward P/S usph.com|Multiplikator Forward P/S PNTG|Rasio kapitalisasi marang dodolan sing dikarepake Organogenesis Holdings|Multiplikator Forward P/S NUTX (nutexhealth.com)|Auna SA (AUNA) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|SBC: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Jeuveau EOLS|CYH (Community Health Systems Inc) - Multiplikator forward rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan MDWD|Rasio rega marang prakiraan pendapatan biote Corp.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep thejoint.com JYNT|Multiplikator Forward P/S DCGO|Multiplikator forward rega marang pendapatan P3 Health PIII|Multiplikator Forward P/S GANX (Gain Therapeutics Inc.)|Multiplikator Forward P/S EUDA Health Holdings Limited EUDA|baselmedical.com - Multiplikator Forward P/S|CLGN: Rasio rega marang prakiraan pendapatan|Cuprina Holdings (Cayman) Ltd. (CUPR) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Concord Medical|AMS (American Shared Hospital Services Inc) - Multiplikator Forward P/S|MEDIROM Corp (MRM) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S ALBT|Rasio kapitalisasi marang dodolan sing dikarepake DIH Holding|Multiplikator Forward P/S XAGE (carmellcosmetics.com)|NIVF: Kapitalisasi marang prakiraan pendapatan|ATIP: Multiplikator forward rega marang pendapatan|CareMax Medical Group - Rasio rega marang pendapatan sing dikarepake|Kindly MD (KDLY) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan MODV|Rasio rega marang prakiraan pendapatan Novo Integrated Sciences Corp|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep SunLink Health Systems SSY|Rasio rega marang prakiraan pendapatan IMAC Corp (BACK)